000			01463 a2200433 4500
005			20250513043957.0
264		0	_c19950124
008			199501s 0 0 eng d
022			_a0923-2516
024	7		_a10.1016/s0923-2516(07)80025-2 _2doi
040			_aNLM _beng _cNLM
100	1		_aBender, A
245	0	0	_aInhibition of HIV in vitro by antiviral drug-targeting using nanoparticles. _h[electronic resource]
260			_bResearch in virology _c
300			_a215-20 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAntiviral Agents _xadministration & dosage
650	0	4	_aHIV Infections _xdrug therapy
650	0	4	_aHIV-1 _xdrug effects
650	0	4	_aHumans
650	0	4	_aIn Vitro Techniques
650	0	4	_aMacrophages _xdrug effects
650	0	4	_aMicroscopy, Electron
650	0	4	_aMicrospheres
650	0	4	_aMonocytes _xdrug effects
650	0	4	_aPhagocytosis
650	0	4	_aPharmaceutical Vehicles
650	0	4	_aSerum Albumin
650	0	4	_aZalcitabine _xadministration & dosage
650	0	4	_aZidovudine _xadministration & dosage
700	1		_aSchfer, V
700	1		_aSteffan, A M
700	1		_aRoyer, C
700	1		_aKreuter, J
700	1		_aRübsamen-Waigmann, H
700	1		_avon Briesen, H
773	0		_tResearch in virology _gvol. 145 _gno. 3-4 _gp. 215-20
856	4	0	_uhttps://doi.org/10.1016/s0923-2516(07)80025-2 _zAvailable from publisher's website
999			_c7800312 _d7800312